310 related articles for article (PubMed ID: 8799560)
1. Effect of 1-aminocyclopropanecarboxylic acid on N-methyl-D-aspartate-stimulated [3H]-noradrenaline release in rat hippocampal synaptosomes.
Clos MV; Garcia Sanz A; Trullas R; Badia A
Br J Pharmacol; 1996 Jun; 118(4):901-4. PubMed ID: 8799560
[TBL] [Abstract][Full Text] [Related]
2. GV 150526A, 7-Cl-kynurenic acid and HA 966 antagonize the glycine enhancement of N-methyl-D-aspartate-induced [3H]noradrenaline and [3H]dopamine release.
Mennini T; Mancini L; Reggiani A; Trist D
Eur J Pharmacol; 1997 Oct; 336(2-3):275-81. PubMed ID: 9384243
[TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV-1 envelope protein gp120, external pH and protein kinase C inhibition.
Pittaluga A; Pattarini R; Feligioni M; Raiteri M
J Neurochem; 2001 Jan; 76(1):139-48. PubMed ID: 11145986
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings.
Pittaluga A; Raiteri M
Eur J Neurosci; 1994 Nov; 6(11):1743-9. PubMed ID: 7874313
[TBL] [Abstract][Full Text] [Related]
5. Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices.
Pittaluga A; Bonfanti A; Arvigo D; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):272-9. PubMed ID: 10344525
[TBL] [Abstract][Full Text] [Related]
6. Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120.
Pittaluga A; Pattarini R; Severi P; Raiteri M
AIDS; 1996 May; 10(5):463-8. PubMed ID: 8724036
[TBL] [Abstract][Full Text] [Related]
7. Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.
Viu E; Zapata A; Capdevila JL; Fossom LH; Skolnick P; Trullas R
J Pharmacol Exp Ther; 1998 May; 285(2):527-32. PubMed ID: 9580593
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors.
Fink K; Schultheiss R; Göthert M
Br J Pharmacol; 1992 May; 106(1):67-72. PubMed ID: 1380384
[TBL] [Abstract][Full Text] [Related]
9. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.
Suárez LM; Solís JM
Eur J Neurosci; 2006 Jul; 24(2):405-18. PubMed ID: 16836643
[TBL] [Abstract][Full Text] [Related]
10. Age-related decrease of the NMDA receptor-mediated noradrenaline release in rat hippocampus and partial restoration by D-cycloserine.
Pittaluga A; Fedele E; Risiglione C; Raiteri M
Eur J Pharmacol; 1993 Jan; 231(1):129-34. PubMed ID: 8444277
[TBL] [Abstract][Full Text] [Related]
11. Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors.
Pittaluga A; Pattarini R; Raiteri M
Eur J Pharmacol; 1995 Jan; 272(2-3):203-9. PubMed ID: 7713164
[TBL] [Abstract][Full Text] [Related]
12. Glycine stimulates [3H]noradrenaline release by activating a strychnine-sensitive receptor present in rat hippocampus.
Raiteri M; Fontana G; Fedele E
Eur J Pharmacol; 1990 Aug; 184(2-3):239-50. PubMed ID: 2150375
[TBL] [Abstract][Full Text] [Related]
13. Endogenous glycine modulates N-methyl-D-aspartate-evoked release of adenosine and [3H]noradrenaline from rat cortical slices.
Craig CG; White TD
Eur J Pharmacol; 1991 May; 197(1):1-7. PubMed ID: 1832638
[TBL] [Abstract][Full Text] [Related]
14. Gp120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons.
Fontana G; Valenti L; Raiteri M
J Neurosci Res; 1997 Sep; 49(6):732-8. PubMed ID: 9335260
[TBL] [Abstract][Full Text] [Related]
15. Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co-expressed on rat and human noradrenergic terminals.
Luccini E; Musante V; Neri E; Brambilla Bas M; Severi P; Raiteri M; Pittaluga A
Br J Pharmacol; 2007 Aug; 151(7):1087-94. PubMed ID: 17592518
[TBL] [Abstract][Full Text] [Related]
16. Modulation of N-methyl-D-aspartate (NMDA)-stimulated noradrenaline release in rat brain cortex by presynaptic alpha 2-adrenoceptors.
Fink K; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):372-8. PubMed ID: 7904051
[TBL] [Abstract][Full Text] [Related]
17. Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N-methyl-D-aspartate receptors.
Nahum-Levy R; Fossom LH; Skolnick P; Benveniste M
Mol Pharmacol; 1999 Dec; 56(6):1207-18. PubMed ID: 10570048
[TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the effects of ethanol and the competitive glycine antagonist 7-chlorokynurenic acid on N-methyl-D-aspartic acid-induced neurotransmitter release from rat hippocampal slices.
Woodward JJ
J Neurochem; 1994 Mar; 62(3):987-91. PubMed ID: 7906723
[TBL] [Abstract][Full Text] [Related]
20. Modulation of dopamine and noradrenaline release and of intracellular Ca2+ concentration by presynaptic glutamate receptors in hippocampus.
Malva JO; Carvalho AP; Carvalho CM
Br J Pharmacol; 1994 Dec; 113(4):1439-47. PubMed ID: 7534187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
